Boehringer Ingelheim receives positive CHMP opinion for adalimumab bios
Committee for Medicinal Products for Human Use (CHMP) of the European Medici...
2017-09-19
文传商讯
Samsung Bioepis' Marketing Authorization Application for SB3 Trastuzuma
SB3, a biosimilar candidate referencing Herceptin (trastuzumab), is Samsung ...
2016-10-11
文传商讯
Samsung Bioepis Becomes First to Obtain European Commission Approval fo
Samsung Bioepis solidifies industry leadership in biosimilars by becoming th...
2016-05-30
文传商讯
